Transmural penetration of intravenously applied microbubbles during contrast-enhanced ultrasound as a new diagnostic feature in patients with GVHD of the bowel

Bone Marrow Transplantation

Volumn 46, Issue 7, 2011, Pages 1006-1011

  Schreyer, A G ^a   Landfried, K ^a   Zorger, N ^a   Hoffstetter, P ^a   Ammer, J ^a   Fellner, C ^a   Friedrich, C ^a   Andreesen, R ^a   Holler, E ^a   Jung, E M ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

contrast media; GVHD; ultrasound

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; CONTRAST ENHANCED ULTRASOUND; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; INTESTINE WALL; INTRAABDOMINAL FAT; MALE; MICROBUBBLE; MICROMORPHOLOGY; PERMEABILITY BARRIER; PRIORITY JOURNAL; SIGNAL NOISE RATIO; ULTRASOUND TRANSDUCER;

ADOLESCENT; ADULT; CONTRAST MEDIA; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMAGE ENHANCEMENT; INFUSIONS, INTRAVENOUS; INTESTINAL DISEASES; MALE; MICROBUBBLES; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 79960192537     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.232     Document Type: Article

References (21)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009; 373: 1550-1561.
2. Washington K, Jagasia M. Pathology of graft-versus-host disease in the gastrointestinal tract. Human Pathol 2009; 40: 909-917.
3. Martin PJ, Schoch G, Fisher L, Byers V, Appelbaum FR, McDonald GB, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77: 1821-1828.
4. Schreyer AG, Finkenzeller T, Gossmann H, Daneschnejad M, Muller-Wille R, Schacherer D, et al. Microcirculation and perfusion with contrast-enhanced ultrasound (CEUS) in Crohns disease: first results with linear contrast harmonic imaging (CHI). Clin Hemorheol Microcirc 2008; 40: 143-155.
5. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
6. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. (Pubitemid 41754712)
7. Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol 1999; 9(Suppl 3): S347-S348.
8. Ma Q, Ma Y, Gong X, Zhang D. Improvement of tissue harmonic imaging using the pulse-inversion technique. Ultrasound Med Bio 2005; 31: 889-894. (Pubitemid 40828627)
9. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003; 227: 361-370. (Pubitemid 36514748)
10. Brodoefel H, Bethge W, Vogel M, Fenchel M, Faul C, Wehrmann M, et al. Early and late-onset acute GvHD following hematopoietic cell transplantation: CT features of gastrointestinal involvement with clinical and pathological correlation. Eur J Radiol 2010; 73: 594-600.
11. Schulenburg A, Turetschek K, Wrba F, Vogelsang H, Greinix HT, Keil F, et al. Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol 2004; 83: 101-106. (Pubitemid 38159613)
12. Worawattanakul S, Semelka RC, Kelekis NL, Sallah AS. MR findings of intestinal graft-versus-host disease. Magn Reson Imaging 1996; 14: 1221-1223. (Pubitemid 27124220)
13. Mentzel HJ, Kentouche K, Kosmehl H, Gruhn B, Vogt S, Sauerbrey A, et al. US and MRI of gastrointestinal graftversus-host disease. Pediatr Radiol 2002; 32: 195-198.
14. Klein SA, Martin H, Schreiber-Dietrich D, Hermann S, Caspary WF, Hoelzer D, et al. A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imaging. Br J Haematol 2001; 115: 929-934. (Pubitemid 34042912)
15. Gorg C, Wollenberg B, Beyer J, Stolte MS, Neubauer A. High-resolution ultrasonography in gastrointestinal graftversus-host disease. Ann Hematol 2005; 84: 33-39. (Pubitemid 39618778)
16. Fegan C, Poynton CH, Whittaker JA. The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990; 5: 373-377. (Pubitemid 20344118)
17. Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, et al. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol 2010; 159: 87-92.
18. Melson J, Jakate S, Fung H, Arai S, Keshavarzian A. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol 2007; 82: 881-886. (Pubitemid 47502693)
19. Ertault-Daneshpouy M, Leboeuf C, Lemann M, Bouhidel F, Ades L, Gluckman E, et al. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 2004; 103: 4681-4684. (Pubitemid 38746004)
20. Kalhs P, Brugger S, Schwarzinger I, Greinix HT, Keil F, Kyrle PA, et al. Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis. Transplantation 1995; 60: 949-957.
21. Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989; 73: 2018-2024. (Pubitemid 19145140)